• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝血管肉瘤 14 年的长期生存。

Long-term 14-year survival with primary hepatic angiosarcoma.

机构信息

Hepatopancreatobiliary Surgery, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia

Hepatopancreatobiliary Surgery, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.

出版信息

BMJ Case Rep. 2022 Aug 10;15(8):e250856. doi: 10.1136/bcr-2022-250856.

DOI:10.1136/bcr-2022-250856
PMID:35948361
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9379495/
Abstract

Primary hepatic angiosarcomas (PHAs) are rare primary liver malignancies with poor outcomes due to their aggressive nature and the difficulty it presents in terms of diagnosis and management. However, early diagnosis and aggressive surgical resection combined with ongoing surveillance can confer prolonged survival in patients with PHA. Additionally, adjuvant radiotherapy may be of benefit in cases of involved surgical margins. Here we report the longest surviving patient with PHA in literature to date. The patient had an initial right hemihepatectomy 14 years ago and 10 years later had a segment III segmentectomy for recurrence on surveillance imaging. This was followed with adjuvant radiotherapy for involved margins. There has been no further recurrence noted on imaging to date, and the patient is continuing to thrive in the community.

摘要

原发性肝血管肉瘤(PHAs)是一种罕见的原发性肝脏恶性肿瘤,由于其侵袭性和诊断及治疗方面的困难,预后较差。然而,早期诊断和积极的手术切除并结合持续的监测可以延长 PHA 患者的生存时间。此外,对于有手术切缘受累的病例,辅助放疗可能有益。在此,我们报告了迄今为止文献中最长生存的 PHA 患者。该患者 14 年前行初始右半肝切除术,10 年后因监测影像学显示复发而行 III 段节段切除术。随后对受累切缘行辅助放疗。迄今为止,影像学检查未发现进一步复发,患者在社区中继续茁壮成长。

相似文献

1
Long-term 14-year survival with primary hepatic angiosarcoma.原发性肝血管肉瘤 14 年的长期生存。
BMJ Case Rep. 2022 Aug 10;15(8):e250856. doi: 10.1136/bcr-2022-250856.
2
[Breast angiosarcoma induced by radiotherapy - surgical treatment options and review of literature].[放疗诱发的乳腺血管肉瘤——手术治疗选择及文献综述]
Rozhl Chir. 2017 Fall;96(8):353-358.
3
Results of hepatic resection for primary hepatic angiosarcoma in adults.成人原发性肝血管肉瘤肝切除术的结果。
Med Sci Monit. 2010 Feb;16(2):CR61-6.
4
A case of hepatic angiosarcoma surviving for more than 16 months after hepatic resection.1例肝血管肉瘤肝切除术后存活超过16个月。
Hepatogastroenterology. 2007 Mar;54(74):533-5.
5
Primary hepatic angiosarcoma: A report of two cases and literature review.原发性肝血管肉瘤:两例报告及文献复习
World J Gastroenterol. 2015 May 21;21(19):6088-96. doi: 10.3748/wjg.v21.i19.6088.
6
Investigation of Prognostic Features in Primary Cutaneous and Soft Tissue Angiosarcoma After Surgical Resection: A Retrospective Study.手术切除后原发性皮肤和软组织血管肉瘤预后特征的调查:一项回顾性研究。
Ann Plast Surg. 2017 Mar;78(3 Suppl 2):S41-S46. doi: 10.1097/SAP.0000000000001004.
7
Tumor Biology Impacts Survival in Surgically Managed Primary Hepatic Vascular Malignancies.肿瘤生物学影响原发性肝血管恶性肿瘤手术治疗的生存。
J Surg Res. 2021 Aug;264:481-489. doi: 10.1016/j.jss.2021.02.043. Epub 2021 Apr 12.
8
Hepatic angiosarcoma: long-term survival after complete surgical removal.肝血管肉瘤:完整手术切除后的长期生存情况
Am Surg. 2000 Dec;66(12):1153-7.
9
Contrast-enhanced ultrasound in diagnosis of primary hepatic angiosarcoma.超声造影在原发性肝血管肉瘤诊断中的应用
J Med Ultrason (2001). 2017 Jul;44(3):267-270. doi: 10.1007/s10396-016-0761-6. Epub 2016 Dec 1.
10
Surgical therapy of primary hepatic angiosarcoma.原发性肝血管肉瘤的外科治疗
BMC Surg. 2019 Jan 10;19(1):5. doi: 10.1186/s12893-018-0465-5.

本文引用的文献

1
A pooled analysis of primary hepatic angiosarcoma.原发性肝血管肉瘤的汇总分析。
Jpn J Clin Oncol. 2020 May 5;50(5):556-567. doi: 10.1093/jjco/hyaa017.
2
Hepatic Angiosarcoma: A Multi-institutional, International Experience with 44 Cases.肝血管肉瘤:44 例多机构、国际经验。
Ann Surg Oncol. 2019 Feb;26(2):576-582. doi: 10.1245/s10434-018-7062-9. Epub 2018 Nov 19.
3
Herald bleeding from a ruptured primary hepatic angiosarcoma: A case report.原发性肝血管肉瘤破裂所致前驱性出血:一例报告
Mol Clin Oncol. 2015 Sep;3(5):1063-1066. doi: 10.3892/mco.2015.575. Epub 2015 Jun 9.
4
Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.磷脂酶Cγ1(PLCG1)R707Q突变在肝血管肉瘤患者的靶向治疗中被反向选择。
Oncotarget. 2015 Nov 3;6(34):36418-25. doi: 10.18632/oncotarget.5503.
5
Primary hepatic angiosarcoma: A report of two cases and literature review.原发性肝血管肉瘤:两例报告及文献复习
World J Gastroenterol. 2015 May 21;21(19):6088-96. doi: 10.3748/wjg.v21.i19.6088.
6
Primary hepatic angiosarcoma: multi-institutional comprehensive cancer centre review of multiphasic CT and MR imaging in 35 patients.原发性肝血管肉瘤:多机构综合癌症中心对35例患者的多期CT和MR成像的回顾
Eur Radiol. 2015 Feb;25(2):315-22. doi: 10.1007/s00330-014-3442-0. Epub 2014 Oct 4.
7
Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma.转录因子ERG是肝血管肉瘤的一种特异性且敏感的诊断标志物。
World J Gastroenterol. 2014 Apr 7;20(13):3672-9. doi: 10.3748/wjg.v20.i13.3672.
8
Primary hepatic angiosarcoma and potential treatment options.原发性肝血管肉瘤及潜在治疗选择。
J Gastroenterol Hepatol. 2014 May;29(5):906-11. doi: 10.1111/jgh.12506.
9
Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience.肝血管肉瘤:肝移植的绝对禁忌证——欧洲肝移植登记处的经验。
Transplantation. 2013 Mar 27;95(6):872-7. doi: 10.1097/TP.0b013e318281b902.
10
Hepatic angiosarcoma. Presentation of two cases.
Rev Esp Enferm Dig. 2009 Jun;101(6):430-4, 434-7. doi: 10.4321/s1130-01082009000600010.